Project Description

EpiBone
The Future of Regenerative Medicine

Date & Time:

March 16, 12:00 PM ET / 9:00 AM PT
Webinar: Details provided upon RSVP approval

About the Event:

Dr. Robert Langer has been granted over 1,400 patents, been cited in more than 331,000 scholarly publications, and written more than 1,500 articles. He’s also a founding father of Moderna, the pharmaceutical company that is helping bring COVID-19 under control. And now you have a chance to hear directly from him thanks to FORCE Family Office.

15-years ago, Dr. Nina Tandon was a bio-engineering student in his lab, where she began her work on electrical signaling in the context of tissue engineering. After receiving her Masters at MIT, and two PhDs from Columbia, she founded EpiBone, a company that is growing bone tissues in a bio-reactor for use in facial reconstruction surgery with Dr. Langer’s support.

Please join us March 16, as Drs. Langer and Tandon discuss investing in BioTech companies and the promise that EpiBone’s work has for the future.

Share this Event

All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.